Dissecting the physiology of multipotent mesenchymal stromal cells to develop vaccine candidates for respiratory disease

  • Heng, Tracy (Primary Chief Investigator (PCI))
  • Boyd, Richard (Chief Investigator (CI))
  • Itescu, Silviu (Partner Investigator (PI))

    Project: Research

    Project Details

    Project Description

    Asthma is a serious and common condition, and for many sufferers there is only limited control and rarely resolution. We propose to produce new multipotent mesenchymal stromal cell products and use them to elucidate the mechanisms by which these cells inhibit allergic asthma. Understanding how these cells inhibit inflammation in the lungs will lead to the rational design of vaccine for respiratory diseases that currently have no cure.

    Funded by: Australian Research Council and Mesoblast
    StatusFinished
    Effective start/end date29/06/1231/12/16

    Activities

    • 1 Membership of industry collaboration/ network

    Mesoblast Limited (External organisation)

    Tracy Heng (Member)

    20122018

    Activity: Industry, Government and Philanthropy Engagement and PartnershipsMembership of industry collaboration/ network